Neuren Pharmaceuticals LimitedASX: NEU

Rett Syndrome NDA accepted for Priority Review by FDA

Sep 13, 2022 at 3:32 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment